Clinical and translational outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease receiving vedolizumabK. D. Williamson,S. Slevin,C. Willberg,R. Chapman,P. Klenerman,S. KeshavGASTROENTEROLOGY(2017)引用 2|浏览22暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要